Entry - #618528 - MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16 - OMIM
# 618528

MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
17q23.3 ?Mitochondrial DNA depletion syndrome 16 (hepatic type) 618528 AR 3 POLG2 604983
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
ABDOMEN
External Features
- Abdominal distention
Liver
- Hepatic failure
- Hepatomegaly
- Microvesicular steatosis seen on liver biopsy
- Panlobular fibrosis
- Cholestasis
- Abnormal mitochondrial morphology
Gastrointestinal
- Poor feeding
SKIN, NAILS, & HAIR
Skin
- Jaundice
NEUROLOGIC
Central Nervous System
- Thin corpus callosum
METABOLIC FEATURES
- Metabolic acidosis
HEMATOLOGY
- Coagulation defects secondary to liver dysfunction
LABORATORY ABNORMALITIES
- Abnormal liver enzymes
- Increased bilirubin
- Increased bile acids
- Increased serum lactate
- Decreased albumin
- Abnormal carnitine profile
- Depletion of mtDNA in various tissues
MISCELLANEOUS
- Onset in the neonatal period
- Death in infancy
- One patient has been reported (last curated August 2019)
MOLECULAR BASIS
- Caused by mutation in the polymerase, DNA, gamma-2 gene (POLG2, 604983.0006)
Mitochondrial DNA depletion syndrome - PS603041 - 24 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
2p23.3 Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) AR 3 256810 MPV17 137960
2p13.1 Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) AR 3 251880 DGUOK 601465
2p11.2 Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria) AR 3 245400 SUCLG1 611224
3q29 ?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type) AR 3 616896 OPA1 605290
4q35.1 Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD AD 3 617184 SLC25A4 103220
4q35.1 Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR AR 3 615418 SLC25A4 103220
6q16.1-q16.2 Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type) AR 3 615471 FBXL4 605654
7p22.3 Mitochondrial DNA depletion syndrome 17 AR 3 618567 MRM2 606906
7q34 Sengers syndrome AR 3 212350 AGK 610345
8q22.3 Mitochondrial DNA depletion syndrome 8B (MNGIE type) AR 3 612075 RRM2B 604712
8q22.3 Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) AR 3 612075 RRM2B 604712
10q21.1 ?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) AR 3 617156 TFAM 600438
10q24.31 Mitochondrial DNA depletion syndrome 7 (hepatocerebral type) AR 3 271245 TWNK 606075
13q14.2 Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria) AR 3 612073 SUCLA2 603921
14q13.3 ?Mitochondrial DNA depletion syndrome 18 AR 3 618811 SLC25A21 607571
15q26.1 Mitochondrial DNA depletion syndrome 4B (MNGIE type) AR 3 613662 POLG 174763
15q26.1 Mitochondrial DNA depletion syndrome 4A (Alpers type) AR 3 203700 POLG 174763
16q21 Mitochondrial DNA depletion syndrome 2 (myopathic type) AR 3 609560 TK2 188250
17q12 Mitochondrial DNA depletion syndrome 20 (MNGIE type) AR 3 619780 LIG3 600940
17q23.3 ?Mitochondrial DNA depletion syndrome 16B (neuroophthalmic type) AR 3 619425 POLG2 604983
17q23.3 ?Mitochondrial DNA depletion syndrome 16 (hepatic type) AR 3 618528 POLG2 604983
17q25.3 ?Mitochondrial DNA depletion syndrome 19 AR 3 618972 SLC25A10 606794
20p11.23 Mitochondrial DNA depletion syndrome 11 AR 3 615084 MGME1 615076
22q13.33 Mitochondrial DNA depletion syndrome 1 (MNGIE type) AR 3 603041 TYMP 131222

TEXT

A number sign (#) is used with this entry because of evidence that mitochondrial DNA depletion syndrome-16 (MTDPS16) is caused by homozygous mutation in the POLG2 gene (604983) on chromosome 17q23. One such patient has been reported.

For a discussion of genetic heterogeneity of autosomal recessive mtDNA depletion syndromes, see MTDPS1 (603041).


Clinical Features

Varma et al. (2016) reported a 3-month-old boy with fulminant neonatal hepatic failure resulting in death at 9 months of age (Hoff et al., 2018). The patient presented with poor feeding, difficulty breathing, and abdominal distention. Laboratory studies showed profound metabolic acidosis, increased lactate, hyperkalemia, elevated liver enzymes, elevated total bilirubin and bile acids, decreased albumin, and coagulopathy. He also an abnormal carnitine profile, suggesting mitochondrial dysfunction. Liver biopsy showed microvesicular steatosis, cholestasis, and panlobular fibrosis, as well as abnormally shaped mitochondria. Severe mtDNA depletion was seen in the liver (25% of control levels), muscle (20%), and blood leukocytes (44%). Muscle biopsy was essentially normal aside from mtDNA depletion and mild ultrastructural alterations in mitochondria. Neurologic examination was unremarkable and muscle tone was normal; brain imaging showed thin corpus callosum. Family history revealed that the mother of the proband had 2 early first trimester miscarriages and a stillbirth at 8 months.


Inheritance

The transmission pattern of MTDPS16 in the family reported by Varma et al. (2016) was consistent with autosomal recessive inheritance.


Molecular Genetics

In a male infant with MTDPS16, Varma et al. (2016) identified a homozygous c.544C-T transition in the POLG2 gene, resulting in an arg182-to-trp (R182W) substitution (R182W; 604983.0006) at a residue in the dimerization base that is conserved in vertebrates. The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was found in the heterozygous state in each unaffected parent, confirming segregation. The variant was not found in the 1000 Genomes Project, Exome Variant Server, or ExAC databases. Functional studies of the variant were not performed, but it was predicted to disrupt POLG2 homodimerization and cause loss of progressive mtDNA synthesis. Patient tissues showed variable degrees of mtDNA depletion.

Hoff et al. (2018) performed functional studies on the R182W variant. Patient-derived fibroblasts showed a growth defect associated with reduced mtDNA copy number and decreased mRNA levels of both POLG (174763) and POLG2 compared to controls. HEK293 cells transfected with the mutation showed defective oxidative phosphorylation, impaired respiratory activity, and decreased ATP production. The R182W protein showed similar DNA-binding abilities and association with POLG as wildtype POLG2. However, the mutant protein showed reduced thermostability, suggesting structural instability, and impaired ability to stimulate POLG compared to wildtype.


REFERENCES

  1. Hoff, K. E., DeBalsi, K. L., Sanchez-Quintero, M. J., Longley, M. J., Hirano, M., Naini, A. B., Copeland, W. C. Characterization of the human homozygous R182W POLG2 mutation in mitochondrial DNA depletion syndrome. PLoS One 13: e0203198, 2018. Note: Electronic Article. [PubMed: 30157269, related citations] [Full Text]

  2. Varma, H., Faust, P. L., Iglesias, A. D., Lagana, S. M., Wou, K., Hirano, M., DiMauro, S., Mansukani, M. M., Hoff, K. E., Nagy, P. L., Copeland, W. C., Naini, A. B. Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion. Europ. J. Med. Genet. 59: 540-545, 2016. [PubMed: 27592148, related citations] [Full Text]


Creation Date:
Cassandra L. Kniffin : 08/08/2019
alopez : 08/12/2019
ckniffin : 08/08/2019

# 618528

MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16


DO: 0070446;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
17q23.3 ?Mitochondrial DNA depletion syndrome 16 (hepatic type) 618528 Autosomal recessive 3 POLG2 604983

TEXT

A number sign (#) is used with this entry because of evidence that mitochondrial DNA depletion syndrome-16 (MTDPS16) is caused by homozygous mutation in the POLG2 gene (604983) on chromosome 17q23. One such patient has been reported.

For a discussion of genetic heterogeneity of autosomal recessive mtDNA depletion syndromes, see MTDPS1 (603041).


Clinical Features

Varma et al. (2016) reported a 3-month-old boy with fulminant neonatal hepatic failure resulting in death at 9 months of age (Hoff et al., 2018). The patient presented with poor feeding, difficulty breathing, and abdominal distention. Laboratory studies showed profound metabolic acidosis, increased lactate, hyperkalemia, elevated liver enzymes, elevated total bilirubin and bile acids, decreased albumin, and coagulopathy. He also an abnormal carnitine profile, suggesting mitochondrial dysfunction. Liver biopsy showed microvesicular steatosis, cholestasis, and panlobular fibrosis, as well as abnormally shaped mitochondria. Severe mtDNA depletion was seen in the liver (25% of control levels), muscle (20%), and blood leukocytes (44%). Muscle biopsy was essentially normal aside from mtDNA depletion and mild ultrastructural alterations in mitochondria. Neurologic examination was unremarkable and muscle tone was normal; brain imaging showed thin corpus callosum. Family history revealed that the mother of the proband had 2 early first trimester miscarriages and a stillbirth at 8 months.


Inheritance

The transmission pattern of MTDPS16 in the family reported by Varma et al. (2016) was consistent with autosomal recessive inheritance.


Molecular Genetics

In a male infant with MTDPS16, Varma et al. (2016) identified a homozygous c.544C-T transition in the POLG2 gene, resulting in an arg182-to-trp (R182W) substitution (R182W; 604983.0006) at a residue in the dimerization base that is conserved in vertebrates. The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was found in the heterozygous state in each unaffected parent, confirming segregation. The variant was not found in the 1000 Genomes Project, Exome Variant Server, or ExAC databases. Functional studies of the variant were not performed, but it was predicted to disrupt POLG2 homodimerization and cause loss of progressive mtDNA synthesis. Patient tissues showed variable degrees of mtDNA depletion.

Hoff et al. (2018) performed functional studies on the R182W variant. Patient-derived fibroblasts showed a growth defect associated with reduced mtDNA copy number and decreased mRNA levels of both POLG (174763) and POLG2 compared to controls. HEK293 cells transfected with the mutation showed defective oxidative phosphorylation, impaired respiratory activity, and decreased ATP production. The R182W protein showed similar DNA-binding abilities and association with POLG as wildtype POLG2. However, the mutant protein showed reduced thermostability, suggesting structural instability, and impaired ability to stimulate POLG compared to wildtype.


REFERENCES

  1. Hoff, K. E., DeBalsi, K. L., Sanchez-Quintero, M. J., Longley, M. J., Hirano, M., Naini, A. B., Copeland, W. C. Characterization of the human homozygous R182W POLG2 mutation in mitochondrial DNA depletion syndrome. PLoS One 13: e0203198, 2018. Note: Electronic Article. [PubMed: 30157269] [Full Text: https://doi.org/10.1371/journal.pone.0203198]

  2. Varma, H., Faust, P. L., Iglesias, A. D., Lagana, S. M., Wou, K., Hirano, M., DiMauro, S., Mansukani, M. M., Hoff, K. E., Nagy, P. L., Copeland, W. C., Naini, A. B. Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion. Europ. J. Med. Genet. 59: 540-545, 2016. [PubMed: 27592148] [Full Text: https://doi.org/10.1016/j.ejmg.2016.08.012]


Creation Date:
Cassandra L. Kniffin : 08/08/2019

Edit History:
alopez : 08/12/2019
ckniffin : 08/08/2019